PLATINUM INVESTMENT MANAGEMENT LTD - Q3 2020 holdings

$4.04 Billion is the total value of PLATINUM INVESTMENT MANAGEMENT LTD's 147 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 2.9% .

 Value Shares↓ Weighting
BLUE  BLUEBIRD BIO INC$27,395,000
-11.6%
507,7840.0%0.68%
-4.2%
HCC  WARRIOR MET COAL INC$13,837,000
+11.0%
810,1200.0%0.34%
+20.0%
LPX  LOUISIANA PAC CORP$7,870,000
+15.1%
266,6730.0%0.20%
+25.0%
ZLAB  ZAI LAB LTDadr$5,684,000
+1.3%
68,3370.0%0.14%
+10.2%
MSFT  MICROSOFT CORP$5,258,000
+3.4%
24,9980.0%0.13%
+12.1%
JNJ  JOHNSON & JOHNSON$3,796,000
+5.9%
25,4950.0%0.09%
+14.6%
BPMC  BLUEPRINT MEDICINES CORP$3,663,000
+18.9%
39,5110.0%0.09%
+30.0%
ALKS  ALKERMES PLC$2,696,000
-14.6%
162,7160.0%0.07%
-6.9%
CHRS  COHERUS BIOSCIENCES INC$2,605,000
+2.7%
142,0340.0%0.06%
+10.3%
DNLI  DENALI THERAPEUTICS INC$2,537,000
+48.2%
70,7930.0%0.06%
+61.5%
ZYME  ZYMEWORKS INC$2,437,000
+29.1%
52,3270.0%0.06%
+39.5%
AGIO  AGIOS PHARMACEUTICALS INC$2,406,000
-34.6%
68,7520.0%0.06%
-28.6%
MRUS  MERUS N V$2,285,000
-25.4%
190,4080.0%0.06%
-18.6%
CAH  CARDINAL HEALTH INC$2,097,000
-10.0%
44,6700.0%0.05%
-1.9%
MRSN  MERSANA THERAPEUTICS INC$2,065,000
-20.4%
110,9060.0%0.05%
-13.6%
MGTA  MAGENTA THERAPEUTICS INC$1,642,000
-9.4%
241,4630.0%0.04%0.0%
BCRX  BIOCRYST PHARMACEUTICALS INC$1,588,000
-27.9%
462,4020.0%0.04%
-22.0%
FPRX  FIVE PRIME THERAPEUTICS INC$1,539,000
-22.9%
327,4140.0%0.04%
-17.4%
RCUS  ARCUS BIOSCIENCES INC$1,492,000
-30.7%
87,0580.0%0.04%
-24.5%
ROKU  ROKU INC$1,397,000
+62.1%
7,3980.0%0.04%
+75.0%
CSCO  CISCO SYS INC$1,406,000
-15.6%
35,7000.0%0.04%
-7.9%
PRTA  PROTHENA CORP PLC$1,281,000
-4.5%
128,2230.0%0.03%
+3.2%
INFI  INFINITY PHARMACEUTICALS INC$1,077,000
+29.4%
920,2940.0%0.03%
+42.1%
PIRS  PIERIS PHARMACEUTICALS INC$1,053,000
-33.2%
508,7680.0%0.03%
-27.8%
XLNX  XILINX INC$960,000
+6.0%
9,2090.0%0.02%
+14.3%
NUVA  NUVASIVE INC$909,000
-12.7%
18,7050.0%0.02%
-8.3%
TWLO  TWILIO INCcl a$787,000
+12.6%
3,1840.0%0.02%
+18.8%
APPN  APPIAN CORPcl a$692,000
+26.3%
10,6930.0%0.02%
+30.8%
FULC  FULCRUM THERAPEUTICS INC$663,000
-56.6%
83,5500.0%0.02%
-54.3%
ALEC  ALECTOR INC$592,000
-56.9%
56,2400.0%0.02%
-51.6%
LUMN  LUMEN TECHNOLOGIES INC$615,000
+0.7%
60,9070.0%0.02%
+7.1%
RNA  AVIDITY BIOSCIENCES INC$422,000
-0.5%
15,0000.0%0.01%0.0%
LBTYA  LIBERTY GLOBAL PLC$311,000
-4.0%
14,8000.0%0.01%
+14.3%
NLSN  NIELSEN HLDGS PLC$241,000
-4.7%
17,0000.0%0.01%0.0%
RAMP  LIVERAMP HLDGS INC$173,000
+21.8%
3,3470.0%0.00%
+33.3%
BITA  BITAUTO HLDGS LTDsponsored ads$090.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTEL CORP42Q3 20238.3%
MICRON TECHNOLOGY INC42Q3 20239.1%
CISCO SYS INC42Q3 20236.9%
EBAY INC.39Q1 20235.9%
INFINITY PHARMACEUTICALS INC39Q4 20220.1%
SKYWORKS SOLUTIONS INC38Q3 20236.0%
ORACLE CORP38Q3 20237.8%
BARRICK GOLD CORPORATION37Q2 20225.4%
JD.COM INC36Q3 20232.8%
MICROSOFT CORP35Q3 20238.9%

View PLATINUM INVESTMENT MANAGEMENT LTD's complete holdings history.

Latest significant ownerships (13-D/G)

View PLATINUM INVESTMENT MANAGEMENT LTD's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G2024-02-12
SC 13G2024-02-12
SC 13G2024-02-12
13F-HR2023-11-03
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
SC 13G2023-02-09
13F-HR2022-11-14

View PLATINUM INVESTMENT MANAGEMENT LTD's complete filings history.

Compare quarters

Export PLATINUM INVESTMENT MANAGEMENT LTD's holdings